These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17139985)

  • 1. Expression of the epidermal growth factor system in endometrial cancer after adjuvant tamoxifen treatment for breast cancer.
    Androutsopoulos G; Adonakis G; Gkermpesi M; Gkogkos P; Ravazoula P; Kourounis G
    Eur J Gynaecol Oncol; 2006; 27(5):490-4. PubMed ID: 17139985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ; Peng YJ; Yu MH; Chen CH
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
    [No Abstract]   [Full Text] [Related]  

  • 3. Subsequent endometrial carcinoma with adjuvant tamoxifen treatment in Japanese breast cancer patients.
    Nishimura N; Hachisuga T; Saito T; Kawarabayashi T
    Int J Gynecol Cancer; 2001; 11(4):272-6. PubMed ID: 11520364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer within tamoxifen-related polyps in patients with breast cancer.
    Tate S; Yamazawa K; Sekiya S
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):769-70. PubMed ID: 15255851
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology - cytohistological correlation in a population of 168 women.
    Buccoliero AM; Fambrini M; Gheri CF; Castiglione F; Garbini F; Barbetti A; Rossi Degl'Innocenti D; Moncini D; Taddei A; Bargelli G; Scarselli G; Marchionni M; Taddei GL
    Gynecol Obstet Invest; 2008; 65(4):240-6. PubMed ID: 18196906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.
    Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ
    Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer.
    Timmerman D; Deprest J; Verbesselt R; Moerman P; De Brabanter J; Vergote I
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S40-2. PubMed ID: 11056312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tamoxifen on cervicovaginal smears from patients with breast cancer.
    Abadi MA; Barakat RR; Saigo PE
    Acta Cytol; 2000; 44(2):141-6. PubMed ID: 10740597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen.
    Turbiner J; Moreno-Bueno G; Dahiya S; Sánchez-Estevez C; Hardisson D; Prat J; Oliva E; Palacios J
    Mod Pathol; 2008 Aug; 21(8):925-36. PubMed ID: 18500270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma].
    Epifani S; Lattarulo S; Maiorino R; Fabiano G
    G Chir; 2000; 21(6-7):310-2. PubMed ID: 10916956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
    Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
    Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.
    Tergas AI; Buell-Gutbrod R; Gwin K; Kocherginsky M; Temkin SM; Fefferman A; Lengyel E; Yamada SD
    Gynecol Oncol; 2012 Nov; 127(2):316-20. PubMed ID: 22835717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
    Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y
    Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen and endometrial cancer: from experiment to patient.
    Assikis VJ; Jordan VC
    Recent Results Cancer Res; 1996; 140():61-71. PubMed ID: 8787078
    [No Abstract]   [Full Text] [Related]  

  • 19. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.